Status:
UNKNOWN
A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19)
Lead Sponsor:
University Hospital, Montpellier
Conditions:
SARS-CoV-2
COVID-19
Eligibility:
All Genders
Brief Summary
SARV-CoV-2 infection was considered pandemic on March 11, 2020. The SARV-CoV-2 epidemic affected France from the beginning of March, spreading in particular from a 4-day large evangelical meeting of 2...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- Patients care at the Montpellier University Hospital suspected of a COVID-19 infection
- Exclusion criteria:
- Patient opposed to the use of his data for research purposes
- Patient deprived of liberty by judicial decision
- Patient not affiliated to a social security scheme
Exclusion
Key Trial Info
Start Date :
February 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04347850
Start Date
February 1 2020
End Date
December 30 2022
Last Update
July 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34280